Advancing Medical Innovation Through Public Policy

KEYWORDS: BILL FRIST, FOOD AND DRUG ADMINISTRATION, JANET MARCHIBRODA

WHEN: Monday, March 16, 2015 6:00 a.m. to 7:30 a.m. ET

WHERE: Bipartisan Policy Center, 1225 Eye St. NW, Suite 1000, Washington, DC, 20005

Add to Calendar

New discoveries and advancements in science have helped Americans live longer, healthier, and more productive lives. As the administration and Congress explore ways to further align public policy with medical innovation and patient access to new medicines and devices, the Bipartisan Policy Center launched a new initiative focused on developing strategies to advance medical innovation within the Food and Drug Administration.

On Monday, March 16, government and private sector experts discussed the actions needed to accelerate the discovery, development and delivery of medical products. Such products will save and improve patients’ lives, reduce the burden of chronic disease, and maintain our nation’s global competitiveness in medical innovation.


Featuring:

Senator Bill Frist, MD
Former Senate Majority Leader
Senior Fellow, Bipartisan Policy Center
@bfrist

Marc Boutin
Chief Executive Officer, National Health Council
@NHCouncil

Congressman Bart Gordon
Former U.S. Representative from Tennessee

Mark McClellan, MD, PhD
Senior Fellow and Director, Health Care Innovation and Value Initiative
Engelberg Center for Health Care Reform, Brookings Institution
@BrookingsMed

Moderated by:

Janet Marchibroda
Director, Health Innovation Initiative
Executive Director, CEO Council on Health and Innovation, Bipartisan Policy Center


Agenda

Welcoming Remarks
10:00AM – 10:05AM

Janet Marchibroda
Director, Health Innovation Initiative
Executive Director, CEO Council on Health and Innovation
Bipartisan Policy Center

Opening Remarks
10:05AM – 10:20AM

Senator Bill Frist, MD
Former Senator Majority Leader
Chair, Bipartisan Policy Center FDA: Advancing Medical Innovation Initiative

Remarks
10:20AM – 10:30AM

Congressman Bart Gordon
Former Member, U.S. House of Representatives
Co-Chair, Bipartisan Policy Center FDA: Advancing Medical Innovation Initiative

Panel Discussion
10:30AM – 11:15AM

Marc Boutin
Chief Executive Officer, National Health Council
Member, Advisory Committee, Bipartisan Policy Center FDA: Advancing Medical Innovation Initiative

Mark McClellan, MD, PhD
Senior Fellow and Director, Health Care Innovation and Value Initiative
Engelberg Center for Health Care Reform, Brookings Institution
Member, Advisory Committee, Bipartisan Policy Center FDA: Advancing Medical Innovation Initiative

Audience Q&A
11:15AM – 11:25AM

Closing Remarks and Adjourn
11:25AM – 11:30AM

Janet Marchibroda
Director, Health Innovation Initiative
Executive Director, CEO Council on Health and Innovation
Bipartisan Policy Center